Lindbrook Capital, LLC - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 109 filers reported holding TREACE MED CONCEPTS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$944
+53.7%
72
+200.0%
0.00%
Q2 2023$614
+1.5%
240.0%0.00%
Q1 2023$605
+9.6%
240.0%0.00%
Q4 2022$552240.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2022
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,581,634$40,458,1973.90%
Millrace Asset Group, Inc. 72,207$1,8471.94%
Perceptive Advisors 2,217,250$56,717,2551.64%
SECTORAL ASSET MANAGEMENT INC 379,443$9,706,1521.62%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,671,9831.56%
EMERALD ADVISERS, LLC 1,366,138$34,945,8101.53%
FORMULA GROWTH LTD 117,750$3,012,0450.96%
OBERWEIS ASSET MANAGEMENT INC/ 251,500$6,433,3700.78%
Novo Holdings A/S 360,000$9,208,8000.71%
Intrinsic Edge Capital Management LLC 354,585$9,070,2840.65%
View complete list of TREACE MED CONCEPTS INC shareholders